Table 4 Impact of number of tissues/organs for ICRP Publication 110 voxelized reference phantoms depending on decreasing ICRP Publication 103 tissue weighting factors, wT, to calculate the effective dose coefficient, e with the SD. The difference in percent calculated according to Eq. 4 and stability according to Eq. 5
Tissue/organ (n = 14) | Tissue weighting factor wT | Effective dose coefficient e (μSv/MBq) | Difference (%) | Stability (%) |
|---|---|---|---|---|
Lungs | 0.12 | 15.3 ± 2.5 | – | 34.7 |
Bone marrow (red) | 0.12 | 15.6 ± 2.3 | 3.2 | 33.6 |
Muscle | Remainder (0.12)† | 18.1 ± 2.1 | 30.5 | 23.0 |
Spleen | Remainder (0.12)† | 19.8 ± 3.0 | 21.5 | 15.5 |
Adrenals glands | Remainder (0.12)† | 20.4 ± 3.3 | 6.7 | 13.2 |
Kidneys | Remainder (0.12)† | 20.9 ± 3.4 | 6.3 | 11.0 |
Heart wall | Remainder (0.12)† | 20.9 ± 3.4 | 0.0 | 11.0 |
Gonads (testes/ovaries) | 0.08 | 20.7 ± 3.4 | -2.6 | 11.9 |
Liver | 0.04 | 22.4 ± 3.9 | 21.2 | 4.6 |
Urinary bladder content | 0.04 | 23.1 ± 3.4 | 8.6 | 1.6 |
Thyroid | 0.04 | 23.3 ± 3.4 | 2.0 | 0.9 |
Brain | 0.01 | 23.4 ± 3.4 | 1.1 | 0.5 |
Salivary glands | 0.01 | 23.5 ± 3.5 | 1.5 | 0.0 |
Pituitary gland | – | 23.5 ± 3.5 | 0.0 | 0.0 |